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ABSTRACT
The purpose of the study was to modify cellulose using hydrochloride salt of 2-aminoethanoyl chloride with 
optimum hydrophilic and hydrophobic properties to impart it a superdisintegrant activity and also to formulate 
and evaluate rapidly disintegrating tablets of metoclopramide hydrochloride using this novel chemically 
modified cellulose. A novel polymer, chemically modified cellulose was synthesized by chemically modifying 
microcrystalline cellulose with hydrochloride salt of 2-aminoethanoyl chloride. The formation of novel polymer 
was confirmed by Fourier Transform Infrared (FTIR) and Nuclear Magnetic Resonance (NMR) spectroscopy and 
by differential scanning calorimetric (DSC) and elemental analysis. The toxicity study proved the novel modified 
cellulose to be non toxic. Rapidly disintegrating tablets of metoclopramide hydrochloride were prepared using 
novel modified cellulose and compared for the release of drug with control formulation, prepared using non 
modified microcrystalline cellulose. The tests like wetting time, water absorption ratio and in vitro disintegration 
time were carried out to elucidate the relationship between them. The study revealed that novel modified 
cellulose in a concentration of 2% released the drug faster than at a concentration higher than that. Hence it could 
be concluded that microcrystalline cellulose, a polymer which is devoid of superdisintegrant activity, can suitably 
be modified by controlled chemical modification of it with hydrochloride salt of 2-aminoethanoyl chloride or 
similar groups with optimum hydrophilicity and hydrophobicity to convert it into a superdisintegrant material. 
It can also be concluded that rapidly disintegrating tablets of metoclopramide hydrochloride can suitably be 
developed for the efficient management of emesis.
KEY WORDS: Chemically modified cellulose, Microcrystalline cellulose, Metoclopramide hydrochloride, 
Rapidly disintegrating tablets, Superdisintegrant.
RESUMEN
The purpose of the study was to modify cellulose using hydrochloride salt of 2-aminoethanoyl chloride with 
optimum hydrophilic and hydrophobic properties to impart it a superdisintegrant activity and also to formulate 
and evaluate rapidly disintegrating tablets of metoclopramide hydrochloride using this novel chemically 
modified cellulose. A novel polymer, chemically modified cellulose was synthesized by chemically modifying 
microcrystalline cellulose with hydrochloride salt of 2-aminoethanoyl chloride. The formation of novel polymer 
was confirmed by Fourier Transform Infrared (FTIR) and Nuclear Magnetic Resonance (NMR) spectroscopy and 
by differential scanning calorimetric (DSC) and elemental analysis. The toxicity study proved the novel modified 
cellulose to be non toxic. Rapidly disintegrating tablets of metoclopramide hydrochloride were prepared using 
novel modified cellulose and compared for the release of drug with control formulation, prepared using non 
modified microcrystalline cellulose. The tests like wetting time, water absorption ratio and in vitro disintegration 
time were carried out to elucidate the relationship between them. The study revealed that novel modified 
cellulose in a concentration of 2% released the drug faster than at a concentration higher than that. Hence it could 
be concluded that microcrystalline cellulose, a polymer which is devoid of superdisintegrant activity, can suitably 
be modified by controlled chemical modification of it with hydrochloride salt of 2-aminoethanoyl chloride or 
similar groups with optimum hydrophilicity and hydrophobicity to convert it into a superdisintegrant material. 
It can also be concluded that rapidly disintegrating tablets of metoclopramide hydrochloride can suitably be 
developed for the efficient management of emesis.
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INTRODUCTION
In the past one decade, there has been an enhanced demand 
for more patient friendly and compliant dosage forms. As 
a result, the demand for developing new technologies 
has been increasing annually. Since the development 
cost of a new drug molecule is very high, efforts are now 
being made by pharmaceutical companies to focus on the 
development of new drug dosage forms for existing drugs 
with improved safety and efficacy together with reduced 
dosing frequency, and the production of more cost effective 
dosage forms1.
Many patients find it difficult to swallow tablets and hard 
gelatin capsules; consequently they do not take medication 
as prescribed. It is estimated that 50% of the population is 
affected by this problem which results in a high incidence 
of incompliance and ineffective therapy2,3. Hence the 
development of an orally disintegrating tablet or rapidly 
disintegrating tablet (RDT) has attracted not only the 
pharmaceutical industry, but also the academia4.
RDTs are preferred by an increasing number of patients 
especially children and elderly, but also adult consumers 
who like to have their medication readily available at any 
time5. This dosage form is also suitable for those who 
are suffering from dysphagia and thus lead to improved 
patient compliance6.
RDTs are useful in bedridden or developmentally 
disabled patients who may face problems in swallowing 
conventional tablets or capsules and liquid orals or syrups 
leading to ineffective therapy, with persistent nausea, 
sudden episodes of allergic attacks or coughing for those 
who have an active life style. RDTs are also useful when 
local action in oral cavity is desirable such as local anesthetic 
for toothaches, oral ulcers, cold sores or teething7-13. Recent 
developments in rapidly disintegrating tablets provide a 
convenient solution for patients who have difficulties in 
swallowing tablets and other solid dosage forms. The solid 
RDT dosage form turns into a soft paste or liquid form for 
easy swallowing, and thus it is free of suffocation risk14.
RDTs are becoming increasingly popular around the 
world. Based on the request from patients to increase their 
treatment and quality of life, new types of RDTs have been 
developed15. RDTs have been in ever increasing demand 
since the last decade and the field has emerged as a rapidly 
developing area in the pharmaceutical field16-19.
Metoclopramide hydrochloride is chemically 4-amino-5-
chloro-N[2-(dimethylamino)-ethyl]-2-methoxybenzamide 
monohydrochloride monohydrate. It is a potent dopamine 
receptor antagonist. It is a potent antiemetic and is effective 
in the treatment of nausea and vomiting associated with 
cancer chemotherapy, pregnancy, migraine etc. It is 
highly water soluble and is rapidly absorbed after oral 
administration. It has a short biological half life (3-5 h) 
and is usually administered in a dose of 10-15 mg four 
times a day. A conventional oral administration has good 
absorption (>90%) but is extensively metabolized by the liver 
(0-68%)20-22. Hence, this drug was selected as a candidate 
drug to formulate a rapidly disintegrating dosage form 
using the novel superdisintegrant, cellulose chemically 
modified with hydrochloride salt of 2-aminoethanoyl 
chloride (1% substitution). 
The present study was aimed to formulate and evaluate 
rapidly disintegrating tablets of metoclopramide 
hydrochloride and also to evaluate chemically modified 
cellulose for its possible superdisintegrant activity.
MATERIALS AND METHODS
Materials
Microcrystalline cellulose, hydrochloride salt of 2- 
aminoethanoic acid and vanilla flavor were procured 
from Rajesh Chemicals (Mumbai, India). Metoclopramide 
hydrochloride was supplied as the gift sample by Mediorals 
Pvt. Ltd. (Satara, India). Spray dried lactose was supplied 
by Medule Pharma (Goa, India). All the other chemicals 
used were of analytical grade and were used as procured.
Experimental Design
Modification of microcrystalline cellulose with 
hydrochloride salt of 2- aminoethanoyl chloride (1% 
substitution): A molar ratio of microcrystalline cellulose 
to hydrochloride salt of 2-aminoethanoyl chloride was 
computed on the basis of molecular weight, number of 
monomers, and free hydroxyl groups present in each 
monomer of microcrystalline cellulose and a molar ratio 
of 1% substitution of microcrystalline cellulose with 
hydrochloride salt of 2-aminoethanoyl chloride was 
calculated. Initially hydrochloride salt of 2-aminoethanoic 
acid was converted to hydrochloride salt of 2-aminoethanoyl 
chloride by reacting with thionyl chloride and distilling 
off the excessive thionyl chloride used in the reaction. 
Microcrystalline cellulose (10g) was added to 200 ml 
of 10% sodium hydroxide solution in water to produce 
swollen alkali cellulose that is chemically more reactive 
than untreated cellulose23. To this swollen alkali cellulose, 
hydrochloride salt of 2- aminoethanoyl chloride (0.54 g) 
was added, and the reaction mixture was heated at 40 0C 
for 36 h. After the completion of reaction, the product was 
filtered and was provided with several washings of water 
to remove excess of alkali and any unreacted hydrochloride 
salt of 2-aminoethanoyl chloride, and traces of thionyl 
chloride if present in product, dried in vacuum desiccator, 
and passed through a #30 mesh screen. The scheme of 
synthesis is given in figure 1.
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Characterization of novel chemically modified cellulose
FTIR spectroscopy: FTIR spectra of microcrystalline 
cellulose and cellulose modified with hydrochloride 
salt of 2-aminoethanoyl chloride were recorded using 
FTIR spectrophotometer (Jasco 4100, Japan) between 
wavelengths of 400-4000cm-1.
NMR spectroscopy: Nuclear magnetic resonance (NMR) 
analysis was done to characterize the modified cellulose 
using a 300 MHz NMR and 1H NMR spectrum was 
recorded on a Varian Mercury 300 MHz spectrometer 
using deutorated chloroform as the solvent.
Thermal analysis: Thermal analysis of cellulose and 
chemically modified cellulose was carried out using 
Mettler Toledo 821e DSC (Switzerland) thermal analyzer. 
Figure 1: Scheme of synthesis of chemically modified cellulose using hydrochloride salt of 2- aminoethanoyl 
chloride.
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Where, R may be H, or –COCH2NH2
The samples (1-2 mg) were hermetically sealed in an 
aluminum pan and heated at a constant rate of 100C per 
minute, over a temperature range of 50 0C- 500 0C. Inert 
atmosphere was maintained by purging nitrogen gas at the 
flow rate of 20 ml/ min.
Elemental analysis: Elemental (C, H, N) analysis of 
cellulose and chemically modified cellulose was done 
using Thermo Finnigan (Thermo Fischer Scientific, U.S.A.) 
elemental analyzer (EA 1112).
Toxicity studies
The acute oral toxicity studies were carried out on 
chemically modified cellulose with hydrochloride salt 
of 2-aminoethanoyl chloride on Swiss Albino Mice 
according to OECD guidelines {OECD guideline No. 425 
Ars Pharm. 2011; 52(3): 26-34.
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(Up and Down Method)} for toxicity studies. The powder 
of test material was suspended in 0.5% CMC in water. 
The suspension was freshly prepared before dosing. 
The concentration of the test material suspensions was 
adjusted to allow administration of all test doses in a 
constant volume. All doses were administered orally to 
the test animals in a constant dosing volume of 0.4 ml /10 g 
bodyweight of the animal. One group of animals acted 
as a control group, which received the vehicle alone in 
a similar manner. The animals were observed for signs 
of intoxication and mortality, if any, up to the end of 14 
days after administration of the dose. The animals were 
observed during the course of treatment for clinical signs 
of toxicity and mortality, body weight, ill health, together 
with any behavioral changes or reaction to treatment. At 
the end of 14 days after dosing, all surviving mice were 
sacrificed under pentothal / ether anesthesia. Complete 
necropsies were carried out on all the animals.  
Preparation of tablets:
Rapidly disintegrating tablets were prepared by direct 
compression according to the formulae given in table 1. All 
the ingredients were passed through # 60 mesh separately, 
weighed accurately and added in a blender in ascending 
order of their weight and blended for 30 min.  The blend 
was then used further to compress the tablets using 10 mm 
normal concave punches to get tablets of 250 mg weight 
on a single punch tablet machine (Cadmach, Ahmedabad, 
India). Control formulation (CF), which contained 
microcrystalline cellulose instead of modified cellulose 
was also formulated to investigate the type of drug release 
from the formulation. A batch of 100 tablets was prepared 
for all the designed formulations.
Characterization of the tablets:
Compatibility Studies:  The compatibility of the drug with 
the excipient was carried out using FTIR spectrophotometer 
(Jasco, 4100, Japan). FTIR spectra were recorded using 
Table 1. Composition of rapidly disintegrating tablets of metoclopramide hydrochloride. 
Ingredients
Formulation
F1 F2 F3 F4 F5 CF
Metoclopramide hydrochloride 10 10 10 10 10 10
Modified Cellulose 5 10 15 20 25 ---
Microcrystalline cellulose --- --- --- --- --- 25
Spray dried lactose 225 220 215 210 205 205
Vanilla flavor 2.5 2.5 2.5 2.5 2.5 2.5
Sodium Saccharine 2.5 2.5 2.5 2.5 2.5 2.5
Magnesium Stearate 2.5 2.5 2.5 2.5 2.5 2.5
Talc 2.5 2.5 2.5 2.5 2.5 2.5
Total Weight 250 250 250 250 250 250
potassium bromide (KBR) dispersion method. The base line 
correction was done using dried potassium bromide. Later 
on the spectrum of dried mixture of drug and potassium 
bromide was run followed by drug with excipients.
Physical parameters: Tablets from all the formulations 
were evaluated for various parameters such as diameter 
(Vernier caliper), thickness (Micrometer screw guage), 
hardness (Pfizer hardness tester), weight variation test and 
friability (Roche friabilator).
Wetting time and water absorption ratio: A piece of 
tissue paper folded twice was kept in a petri dish (internal 
diameter of 5.5 cm) containing ≈ 6 ml of purified water. 
A tablet having a small amount of amaranth powder on 
the upper surface was placed on the tissue paper. The 
time required to develop a red color on the upper surface 
of the tablet was recorded as the wetting time. The same 
procedure without amaranth powder was followed for 
determining the water absorption ratio. The wetted tablet 
was weighed and the water absorption ratio, R, was 
determined according to the equation 113.
   R= {(Wa - Wb) / Wb} x 100    (1) 
Where, Wb and Wa are the weights of the tablet before and 
after study.
In vitro disintegration test: As many reports indicated 
the unsuitability of USP disintegration test apparatus for 
rapidly disintegrating tablets, a more suitable apparatus, 
described by khan et al was developed to study the 
disintegration time of the rapidly disintegrating tablets. 
The apparatus consisted of a glass beaker of 1000 ml 
capacity with the wire basket positioned in the beaker with 
the help of a support in such a way that when the beaker 
contained 900 ml of PBS pH 6.8, the basket had only 6 ml of 
it. A magnetic bead was placed at the bottom of the beaker 
and the temperature of the medium was maintained at 37 
± 2ºC. Disintegration test was performed at 50 rpm and 
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the time required for complete disintegration of the tablets 
was determined. The results of the two methods were 
compared13,24-26.
In Vitro dissolution study: In vitro dissolution study 
of rapidly disintegrating tablets of metoclopramide 
hydrochloride was carried out using USP XXIII type II 
dissolution apparatus (TDT 08L, Electrolab, Mumbai, 
India) employing a paddle stirrer at 50 rpm using 900 
ml of phosphate buffer solution pH 6.8 at 37 ± 0.5 ºC as 
dissolution medium 27. Aliquots of dissolution medium 
were withdrawn at specified time intervals and were 
analyzed for drug content by measuring the absorbance 
at 309 nm. Sink conditions were maintained throughout 
the experiment. Cumulative percent of metoclopramide 
hydrochloride released was calculated using the software 
PCP Disso V3 and plotted against time. The study was 
carried out in triplicate.
Statistical analyses:
The in vitro release data was analyzed statistically using 
the software Graph Pad prism version 4 to analyze whether 
significant difference lies in the in vitro drug release profile 
of formulations containing modified cellulose and the 
control formulation One way ANOVA was performed on 
all the data sets and Dunnett’s multiple comparison test was 
applied to compare between all columns of formulations 
containing modified cellulose with the column of control 
formulation at 95% confidence interval.
RESULTS AND DISCUSSION
Characterization of modified cellulose:
FTIR spectroscopy: From the FTIR spectra of modified 
cellulose and that of cellulose, it was clearly evident that 
the slight change at about 3400 cm-1 can be attributed 
to acylation of a fraction of the free hydroxyl groups 
in cellulose by hydrochloride salt of 2-aminoethanoyl 
chloride. Similarly a slight increase in intensity of the band 
at about 3300 cm-1 was due to the addition of amino group 
to the polymeric structure as shown in figure 2.
NMR spectroscopy: The 1H NMR spectrum of the modified 
polymer, as shown in figure 3, indicates the presence of 
amino group proton at 3.5 ppm which confirms chemical 
modification of cellulose by acylation of a fraction of 
free hydroxyl groups with 2-aminoethanoyl chloride. 
Confirmation of introduction of primary amino group 
along with the presence of carbonyl ester that was indicated 
in the FTIR spectrum is a satisfactory evidence for the 
proposed chemical modification.
Thermal analysis: As both microcrystalline cellulose and 
modified cellulose do not have exact melting points and 
char when heated, no sharp endothermic peaks were 
observed for both of them indicting no exact melting 
points as shown in figure 4. A broad endothermic bend in 
thermogram 3A from 37-105ºC for cellulose and from 
37-118 ºC in thermogram 3B for chemically modified 
cellulose can plausibly be attributable to the glass transition 
of the polymer and the vaporization of the moisture present 
in the samples.
Elemental analysis: The elemental analysis of cellulose 
and novel chemically modified cellulose is summarized 
in table 2. It is to be noted that the empirical formula of 
both polymers can be approximated due to their high 
polydispersity. The theoretical values for C and H are 
42.10%, and 6.43% which correlates well with the observed 
values of 41.90%, and 6.22% respectively. The theoretical 
value for nitrogen was 0.14%, whereas in case of modified 
cellulose, it was 0.12%, exhibiting close resemblance with 
Figure 2: Overlain FTIR 
spectra of microcrystalline 
cellulose (A) and cellulose 
chemically modified with 
hydrochloride salt of 
2-aminoethanoyl chloride (B).
Aloorkar NH, Bhatia MS.
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Figure 3. 1H NMR spectrum of the chemically modified cellulose.
Table 3. Survival data of animals in toxicity studies.
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the values for nitrogen.
Toxicity studies
Toxicity Signs like changes in skin, fur, eyes, mucous 
membranes, occurrence of secretions and excretions and 
autonomic activity such as lacrimation, piloerection, pupil 
size, unusual respiratory pattern, circulatory, autonomic 
and central nervous systems, and somatomotor activity 
were not observed in any of the animal treated with the 
test substances. Changes in gait, posture and response 
to handling as well as the presence of clonic or tonic 
movements, sterotypy or bizarre behavior were not 
observed in any of the animals. Other signs like tremors, 
convulsions, salivation, diarrhea, lethargy, sleep and coma 
were not seen in animal during Study.
The animal that died during study was dissected and 
observed for changes in the alimentary tract. It was 
observed that the animal that died in the study was due 
to severe bloating of alimentary tract and accumulation of 
air in the alimentary tract. These observations suggest that 
the dose administered obstructed the gastrointestinal tract 
and caused severe pressure on vital organs that might had 
resulted into death. In necropsy, no significant changes 
were observed in these animals. The data for the survival 
of the animals during acute oral toxicity study is given in 
table 3.
Compatibility studies
It was found that the important peaks that were present 
Figure 4. Overlain differential scanning calorimetric 
thermograms of microcrystalline cellulose (A) and 
cellulose chemically modified with hydrochloride 
salt of 2-aminoethanoyl chloride (B).
in FTIR spectrum of drug, metoclopramide hydrochloride, 
were found to be present in the FTIR spectra of drug with 
polymers, namely novel modified cellulose, and cellulose 
as shown in Figure 5. Hence it could be concluded that the 
drug and polymers were compatible with each other.
Physical parameters of tablets
Tablets prepared by direct compression method were 
evaluated for various official and non official parameters. 
As the material was free flowing, tablets were obtained of 
uniform weight, due to uniform die fill with acceptable 
variation as per I.P. specification (<5%). Thickness of 
Test Material Survival
Chemically modified cellulose with hydrochloride salt of 2-aminoethanoyl chloride OXOOO
X- Death, O- Survival of animal
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the tablets was found to be in the range of 3.33-3.53 mm 
whereas diameter was observed in the range of 10.06-10.13 
mm. Hardness of the tablets was found to be in the range 
of  3.3 – 3.83 kg/cm2. Friability was found to be below 1% 
which was an indication of good mechanical strength of 
the tablets that can withstand the shocks during shipping 
or transportation. The values obtained for physical 
parameters of the tablets are given in table 4. 
Wetting time and water absorption ratio:
Wetting time was found to be increased from formulation 
F1-F5, which contained novel modified cellulose as the 
superdisintegrant. It was 86.67 Sec for formulation F1 
while it was found to be 180.33 Sec for formulation F5. 
For control formulation (CF), it was found to be 14.55 min. 
The values for wetting time and water absorption ratio are 
given in the table 5.
The water absorption ratio was found to be decreased from 
F1-F5. It was found to be in the range of 80.99% - 50.49% for 
formulations F1-F5. For control formulation, it was found 
to be 45.77%. 
The increase in the wetting time and the decrease in the 
water absorption ratio for formulations F1-F5 may be due 
to reduction in the capillary action, which may be due 
to the blockade of the pores of the formulation. Higher 
value of wetting time and least value of water absorption 
ratio was observed for control formulation. This may be 
due to absence of water soluble groups in the structure of 
microcrystalline cellulose and may be due to poor capillary 
action. 
Disintegration time:
The disintegration times obtained are as given table 5. 
The least disintegration time of 41.33 sec was observed 
in formulation F1, which contained 2% of 1% modified 
cellulose while it was found to be 18.32 min for control 
formulation (CF), which contained non modified 
microcrystalline cellulose. Disintegrating time was found 
to be increasing from F1-F5. 
The superdisintegrant property may be imparted to 
cellulose due to addition of highly hydrophilic and water 
soluble moiety by the way of chemical modification. But 
paradoxically it was found that novel modified cellulose 
in a concentration of 2% is having good superdisintegrant 
activity as compared to its higher concentration in other 
formulations. This may be due to increased number of 
terminal –NH2 groups, which may be responsible for the 
reduction in the capillary action of the compound and may 
possibly resulted into the increased disintegration time of 
the formulation as the same was evident from the wetting 
time and water absorption ratio.
Due to addition of –CO-CH2-NH2 group, the water 
assessable polarity of modified cellulose might have been 
improved due to the presence of an electron withdrawing 
carbonyl group bridged to an electron releasing group 
through a methylene bridge. Therefore the ability of 
modified cellulose to take up water by capillary action 
might have been enhanced and superdisintegrant activity 
might be imparted to it. 
Thus, it can be concluded that this chemical modification 
could account for the reduction in the disintegration time 
Figure 5.Overlain FTIR spectra of metoclopramide 
hydrochloride (A), metoclopramide hydrochloride 
with modified cellulose (B), metoclopramide 
hydrochloride with cellulose (C).
Table 4. Evaluation of Tablets.
Formulation Thickness (mm) Diameter(mm) Hardness (Kg/cm2) Friability(%) Weight Variation Test †
F1 3.4±0.07 10.1± 0.1 3.33±0.28 0.47±0.12 Passes
F2 3.37±0.14 10.13±0.12 3.67±0.29 0.47±0.09 Passes
F3 3.3 ± 0.14 10.06±0.12 3.33±0.21 0.47±0.13 Passes
F4 3.43± 0.07 10.06±0.06 3.67±0.23 0.35±0.18 Passes
F5 3.53± 0.14 10.1±0.1 3.83±0.18 0.31±0.17 Passes
CF 3.47± 0.14 10.13±0.12 3.83±0.18 0.36±0.12 Passes
* indicates the mean of 3 determinations ± SD. † indicates n = 20 
Aloorkar NH, Bhatia MS.
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to the modified cellulose. 
In Vitro Dissolution Study:
For all the designed formulations prepared with modified 
cellulose and unmodified cellulose, the time required 
for complete drug release was found to be different. 
Formulation F1 required 6 min time for complete drug 
release, whereas formulation F5 took 20 min for complete 
drug release. This may be due to an increase in the wetting 
time and a decrease in the water absorption ratio from F1-
F5, which in turn may be due to blockade of the openings 
or a reduction in the capillary action of the formulation 
which contained higher amounts of modified cellulose. The 
complete drug release from formulation F1 was obtained 
in 6 min. whereas the control formulation, CF, was found 
to release the drug completely at the end of 40 min. 
This improved efficiency of the chemically modified 
cellulose can be attributed to relative decrease in non 
bonded polar interactions between the polymer and 
relatively polar drug as the chemically modified cellulose is 
relatively less polar than that of microcrystalline cellulose. 
The in vitro drug release profile for all the formulations is 
as given in table 6 and figure 6. 
Statistical Analyses:
After analyzing statistically it was found that there was a 
significant difference (P<0.05) in the drug release profile 
of formulations containing novel modified cellulose and 
the control formulation. From the statistical analyses it 
was clear that modified cellulose could be a promising 
superdisintegrant.
From the above discussion, it could be concluded that 
formulation F1, which contained 2% novel modified 
cellulose could be the optimized formulation as it took 
least time for disintegration, its water absorption ratio was 
good and wetting time was less, and moreover it released 
the drug in less time (6 min) as compared to formulations 
F2-F5, which contained the same modified cellulose but in 
higher concentrations.
Figure 6. In-vitro dissolution profile of all 
formulations.
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Table 5. Evaluation of Tablets.
Table 6. Time taken for complete drug release 
in PBS pH 6.8.
Formulation Wetting Time  (Sec) Water absorption ratio
Disintegration Time (Sec)
USP  Apparatus Modified Apparatus (50 rpm)
F1 86.67 ±1.53 80.99±0.73 41.33± 1.15 53.67 ± 1.53
F2 102.67 ±1.15 76.50±0.46 91 ±  1.32 111.66 ± 0.57
F3 105 ± 1.19 60.33±0.62 131.67±1.52 145.67 ± 0.59
F4 69.33 ± 1.15 56.38±1.07 141.67±1.53 157.66 ± 2.09
F5 80.33 ± 0.58 50.49±0.50 166.33±0.58 182.33 ± 2.51
CF 14.55±0.02 † 45.77± 0.49 18.39±0.07† 21.86 ± 0.29 †
Formulation
Cumulative % 
drug released*
Time required, 
Min
F1 102.97 ± 0.15 6
F2 101.99 ± 0.32 8
F3 102.83 ± 0.16 10
F4 103.21 ± 0.25 12
F5 99.10 ± 0.21 20
CF 99.78 ± 0.31 40
* indicates the mean of 3 determinations ± SD. † indicates time in min.
* indicates the mean of 3 determinations ± SD. 
CONCLUSION:
Modification of microcrystalline cellulose by controlled 
chemical modification with hydrochloride salt of 
2-aminoethanoyl chloride produced a compound with a 
superdisintegrant activity. The formation of chemically 
modified cellulose was confirmed with FTIR and NMR 
spectroscopy and by elemental and DSC analysis. The acute 
oral toxicity studies proved the novel modified cellulose 
to be non toxic. The drug release studies indicated that 
the modified polymer was able to release the drug faster 
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than unmodified cellulose. Hence it could be concluded 
that microcrystalline cellulose, a polymer which is devoid 
of superdisintegrant activity, can suitably be modified by 
controlled chemical modification of it with hydrochloride 
salt of 2-aminoethanoyl chloride or similar groups with 
optimum hydrophilicity and hydrophobicity to convert it 
into a superdisintegrant material. It can also be concluded 
that an efficient rapidly disintegrating formulation can 
suitably be developed incorporating chemically modified 
cellulose as the superdisintegrant.
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